899 related articles for article (PubMed ID: 9328662)
1. Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle.
Morrill JC; Mebus CA; Peters CJ
Am J Vet Res; 1997 Oct; 58(10):1104-9. PubMed ID: 9328662
[TBL] [Abstract][Full Text] [Related]
2. Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids.
Morrill JC; Mebus CA; Peters CJ
Am J Vet Res; 1997 Oct; 58(10):1110-4. PubMed ID: 9328663
[TBL] [Abstract][Full Text] [Related]
3. Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent rift valley fever virus.
Morrill JC; Peters CJ
J Infect Dis; 2011 Jul; 204(2):229-36. PubMed ID: 21673033
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves.
von Teichman B; Engelbrecht A; Zulu G; Dungu B; Pardini A; Bouloy M
Vaccine; 2011 Aug; 29(34):5771-7. PubMed ID: 21664400
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep.
Dungu B; Louw I; Lubisi A; Hunter P; von Teichman BF; Bouloy M
Vaccine; 2010 Jun; 28(29):4581-7. PubMed ID: 20470792
[TBL] [Abstract][Full Text] [Related]
6. Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes.
Morrill JC; Jennings GB; Caplen H; Turell MJ; Johnson AJ; Peters CJ
Am J Vet Res; 1987 Jul; 48(7):1042-7. PubMed ID: 3631685
[TBL] [Abstract][Full Text] [Related]
7. Adverse response of non-indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine.
Botros B; Omar A; Elian K; Mohamed G; Soliman A; Salib A; Salman D; Saad M; Earhart K
J Med Virol; 2006 Jun; 78(6):787-91. PubMed ID: 16628582
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a formalin-inactivated Rift Valley fever vaccine in sheep.
Harrington DG; Lupton HW; Crabbs CL; Peters CJ; Reynolds JA; Slone TW
Am J Vet Res; 1980 Oct; 41(10):1559-64. PubMed ID: 7224281
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of three candidate Rift Valley fever vaccines in sheep.
Kortekaas J; Antonis AF; Kant J; Vloet RP; Vogel A; Oreshkova N; de Boer SM; Bosch BJ; Moormann RJ
Vaccine; 2012 May; 30(23):3423-9. PubMed ID: 22449427
[TBL] [Abstract][Full Text] [Related]
10. Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep.
Morrill JC; Carpenter L; Taylor D; Ramsburg HH; Quance J; Peters CJ
Vaccine; 1991 Jan; 9(1):35-41. PubMed ID: 2008798
[TBL] [Abstract][Full Text] [Related]
11. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG
Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371
[TBL] [Abstract][Full Text] [Related]
12. Mucosal immunization of rhesus macaques with Rift Valley Fever MP-12 vaccine.
Morrill JC; Peters CJ
J Infect Dis; 2011 Aug; 204(4):617-25. PubMed ID: 21791664
[TBL] [Abstract][Full Text] [Related]
13. Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever.
Wallace DB; Ellis CE; Espach A; Smith SJ; Greyling RR; Viljoen GJ
Vaccine; 2006 Nov; 24(49-50):7181-9. PubMed ID: 16870311
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of a live attenuated Rift Valley Fever recombinant arMP-12ΔNSm21/384 vaccine candidate for sheep, goats and calves.
Boumart Z; Daouam S; Bamouh Z; Jazouli M; Tadlaoui KO; Dungu B; Bettinger G; Watts DM; Elharrak M
Vaccine; 2019 Mar; 37(12):1642-1650. PubMed ID: 30773401
[TBL] [Abstract][Full Text] [Related]
15. An inactivated rift valley fever vaccine.
Barnard BJ; Botha MJ
J S Afr Vet Assoc; 1977 Mar; 48(1):45-8. PubMed ID: 874947
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of lamb and calf responses to Rift Valley fever MP-12 vaccination.
Wilson WC; Bawa B; Drolet BS; Lehiy C; Faburay B; Jasperson DC; Reister L; Gaudreault NN; Carlson J; Ma W; Morozov I; McVey DS; Richt JA
Vet Microbiol; 2014 Aug; 172(1-2):44-50. PubMed ID: 24856133
[TBL] [Abstract][Full Text] [Related]
17. Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine.
Cortese VS; Grooms DL; Ellis J; Bolin SR; Ridpath JF; Brock KV
Am J Vet Res; 1998 Nov; 59(11):1409-13. PubMed ID: 9829398
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves.
Morrill JC; Laughlin RC; Lokugamage N; Wu J; Pugh R; Kanani P; Adams LG; Makino S; Peters CJ
Vaccine; 2013 Oct; 31(43):4988-94. PubMed ID: 23994375
[TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania.
Nyundo S; Adamson E; Rowland J; Palermo PM; Matiko M; Bettinger GE; Wambura P; Morrill JC; Watts DM
Onderstepoort J Vet Res; 2019 Jan; 86(1):e1-e8. PubMed ID: 30843406
[TBL] [Abstract][Full Text] [Related]
20. Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep.
Bird BH; Maartens LH; Campbell S; Erasmus BJ; Erickson BR; Dodd KA; Spiropoulou CF; Cannon D; Drew CP; Knust B; McElroy AK; Khristova ML; Albariño CG; Nichol ST
J Virol; 2011 Dec; 85(24):12901-9. PubMed ID: 21976656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
